ALIADA THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Sept 2025)
What this means for you
This application is over — abandoned 22 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90832349
- Mark type
- Stylized text
- Filed
- 16 Jul 2021
- Published for opposition
- 21 Jun 2022
- Abandoned
- 22 Sept 2025
- Attorney of record
- Cheryl A. Withycombe
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals and therapeutic pharmaceuticals for the treatment of neurological conditions; pharmaceuticals and therapeutic pharmaceuticals for the treatment and prevention of immunological conditions; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer; pharmaceuticals and therapeutic pharmaceuticals for the treatment and prevention of ophthalmic conditions
- Class 042 — Scientific and technological services: research and development of pharmaceuticals and therapeutics in the fields of neurology, immunology, oncology and ophthalmology
Owner
- Aliada Therapeutics, Inc., Boston, MA, US
- Aliada Therapeutics, Inc., Boston, MA, US
Prosecution history
- 22 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 May 2025 — SOU EXTENSION 5 GRANTED
- 10 Feb 2025 — SOU EXTENSION 5 FILED
- 27 May 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2024 — SOU EXTENSION 4 GRANTED
- 15 Jul 2024 — SOU EXTENSION 4 FILED
- 15 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED